<DOC>
	<DOCNO>NCT03037671</DOCNO>
	<brief_summary>This study design determine feasibility use continuous glucose monitor pediatric , adolescent young adult hematopoietic stem cell transplant ( HSCT ) recipient , identify incidence risk factor malglycemia primary admission pediatric , adolescent young adult HSCT patient well characterize relationship outcome malglycemia population .</brief_summary>
	<brief_title>Evaluation Malglycemia Via Continuous Glucose Monitoring Pediatric HSCT Population</brief_title>
	<detailed_description>This study prospective observational cohort analysis examine rate malglycemia pediatric HSCT population effect malglycemia important post-HSCT outcome . In addition usual care peri-HSCT period , participant trial ask wear continuous glucose monitor duration initial hospital admission . Participants wear monitor admit hospital one week prior transplant , 60 day transplant .</detailed_description>
	<criteria>1 . Patients age 2 30 year old time transplant . 2 . Patients undergoing hematopoietic stem cell transplantation CHCO . 3 . Subject willing wear continuous glucose monitor duration study . 4 . Subject willing follow study protocol . 1 . Preexisting diagnosis type 1 diabetes , type 2 diabetes , insulin requirement 2 week precede transplant . 2 . Preexisting condition require use steroid ( HSCT ) 3 . Severe psychiatric disease developmental delay might interfere ability provide inform consent . 4 . Any medical condition opinion investigator impair person 's ability safely participate trial . 5 . Subject active skin condition would affect sensor placement .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Malglycemia</keyword>
</DOC>